bibliographicCitation |
Li J, Di C, Jing J, Di Q, Nakhla J, Adamson DC. OTX2 is a therapeutic target for retinoblastoma and may function as a common factor between C-MYC, CRX, and phosphorylated RB pathways. Int J Oncol. 2015 Nov;47(5):1703–10. doi: 10.3892/ijo.2015.3179. PMID: 26397460. |